Add like
Add dislike
Add to saved papers

Characteristics and outcomes of Indian children enrolled in a rheumatic heart disease registry.

BACKGROUND: Rheumatic heart disease (RHD) causes significant morbidity among children of low and middle-income countries. We aimed to assess characteristics and outcomes of Indian children enrolled in a tertiary care hospital RHD registry.

METHODS: Pediatric patients (≤18years) were prospectively enrolled over three years. We evaluated their clinical and echocardiographic characteristics, valvular interventions, adherence to penicillin prophylaxis, and mortality.

RESULTS: 451 patients were enrolled in the registry (mean age 12.2±3.2years, 34% females). Females had greater burden of exercise intolerance than males (26.8% NYHA classes III-IV versus [vs] 13.8%, p<0.01). Among 388 patients with no prior interventions, mitral regurgitation was the most common lesion (48.7%). 279 patients (71.9%) had severe valvular disease and this proportion was higher in females than males (80.9% vs. 67.6%, p<0.01). 248 patients received AHA/ACC class I recommendation for valvular interventions and 53 (21.4%) underwent an intervention during 11month (median) follow-up. Age (adjusted odds ratio [aOR] 1.18, 95% confidence interval [CI] 1.03-1.36), NYHA classes III-IV (aOR 4.96, 95% CI 2.51-9.60), mitral stenosis (aOR 37.01, 95% CI 6.96-196.74), and mixed mitral valve disease (aOR 2.79, 95% CI 1.03-7.56) were predictive of undergoing an intervention. Mean adherence to penicillin prophylaxis among 274 patients with clinic follow-up was 93.6%. 14 patients (3.1%) died during follow-up.

CONCLUSIONS: Females had greater disease severity in an Indian pediatric RHD registry. Adherence to penicillin prophylaxis in the cohort was good. After 11months follow-up, one in five patients underwent a guideline-recommended intervention. Mortality was high during this short follow-up period.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app